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Abstract: In this study, dextran-encrusted magnetic nanoclusters (DMNCs) were synthesized 
using a one-pot solution phase method for detection of atherosclerosis by magnetic resonance 
imaging. Pyrenyl dextran was used as a surfactant because of its electron-stabilizing effect 
and its amphiphilic nature, rendering the DMNCs stable and water-dispersible. The DMNCs 
were 65.6±4.3 nm, had a narrow size distribution, and were superparamagnetic with a high 
magnetization value of 60.1 emu/g. Further, they showed biocompatibility and high cellular 
uptake efficiency, as indicated by a strong interaction between dextran and macrophages. In vivo 
magnetic resonance imaging demonstrated the ability of DMNCs to act as an efficient magnetic 
resonance imaging contrast agent capable of targeted detection of atherosclerosis. In view of 
these findings, it is concluded that DMNCs can be used as magnetic resonance imaging contrast 
agents to detect inflammatory disease.
Keywords: magnetic nanocrystal, magnetic resonance imaging, atherosclerosis, 
 macrophages, dextran
Introduction
Magnetic nanoparticles have excellent potential in the early diagnosis of a number of 
diseases by magnetic resonance (MR) imaging.1–6 Recently, magnetic nanoparticles 
have been synthesized using various well defined approaches, such as thermal decom-
position and coprecipitation processes. Magnetic nanoparticles synthesized by thermal 
decomposition have well defined crystallinity and magnetic sensitivity.7–15 However, 
they are not soluble in aqueous phase, so have limited biological application.16,17 
Complicated surface modification processes are often used to make magnetic nano-
particles hydrophilic in order to improve their colloidal stability, thereby increasing 
their circulation time in the body and targeting a specific organ/tissue or tumor with 
a high affinity.18–26 For example, Fang et al recently utilized triethoxysilylpropylsuc-
cinic anhydride for surface modification of iron oxide nanoparticles to make them 
water-soluble and biocompatible; they further coupled these with amine-functionalized 
poly(ethylene glycol), leaving the amine groups free and allowing for further conjuga-
tion to various biomolecules for targeting.22 Despite stabilization of such nanoparticles, 
surface modification can significantly increase their size, resulting in limited tissue 
distribution and metabolic clearance from the body.27,28 It is therefore crucial that we 
devise contemporary synthetic methodologies for uncomplicated synthesis of magnetic 
nanoclusters with water-dispersibility, monodispersity, and ease of synthesis.29,30 In this 
work, we used a facile one-pot strategy to synthesize hydrophilic dextran-encrusted 
magnetic nanoclusters (DMNCs) enabling atherosclerosis-targeted MR imaging. 
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Specifically, DMNCs can be used for accurate diagnosis 
of atherosclerosis via MR imaging, and this is rooted in the 
strong interaction between the dextran present on the surface 
of DMNCs with the macrophages present in the atheroscle-
rotic lesions.31–37 Pyrenyl dextran, used as a surfactant, was 
first synthesized using dextran and 1-pyrenebutyric acid, as 
previously reported.32,33 The DMNCs were then synthesized 
with iron precursors and pyrenyl dextran in the solution 
phase. We confirmed the physicochemical properties of 
DMNCs and their usefulness as MR imaging agents for 
detection of atherosclerosis using in vitro/in vivo systems 
(Figure 1).
Materials and methods
Materials
All chemicals and reagents were of analytical grade and used as 
received. 1-Pyrenebutyric acid, 1,3-dicyclohexylcarbodiimide 
(DCC), 4-dimethylaminopyridine, anhydrous dimethyl sulfox-
ide, triethylamine, iron (III) chloride, sodium acetate, diethyl-
ene glycol (DEG), and ethylene glycol were purchased from 
Sigma-Aldrich (St Louis, MO, USA). Dextran T10 (molecular 
weight 10,000 Da) was purchased from Pharmacia Biotech 
(Pfizer, New York City, NY, USA). Phosphate-buffered saline 
(10 mM, pH 7.4), fetal bovine serum, and  Dulbecco’s Modi-
fied Eagle Medium were obtained from Gibco (Carlsbad, CA, 
USA), and the dialysis membrane (molecular weight cutoff 
3,500) was obtained from Pierce (Thermo Fisher Scientific, 
Waltham, MA, USA).  Ultrapure deionized water was used for 
all synthesis procedures.
synthesis of pyrenyl dextran
Pyrenyl dextran, an amphiphilic copolymer, was formed 
using the recommended bioconjugation technique.32,33 The 
hydroxyl group of dextran (molecular weight 10,000 Da) 
was linked to the carboxylic group of 1-pyrenebutyric acid 
(molecular weight 288.34 Da) using DCC and DMAP as the 
coupling agent and catalyst, respectively (Figure 1). A mixture 
of 0.1 mmol of dextran, 4.2 mmol of 1- pyrenebutyric acid, 
0.5 mmol of DCC, 0.5 mmol of 4-dimethylaminopyridine, 
and 0.2 mmol of triethylamine dissolved in 60 mL of dim-
ethyl sulfoxide was reacted for 48 hours at room tempera-
ture followed by lyophilization. To remove the byproducts, 
the resulting mixture was then filtered through a cellulose 
acetate filter (pore size 200 nm) after being dissolved in 
excess deionized water. For further purification, dialysis was 
performed over 7 days. The purified product was lyophilized 
under vacuum and stored for later use. Characterization of 
the as-synthesized pyrenyl dextran was completed using 
Fourier-transform infrared spectroscopy (Excalibur series, 
Varian Inc., Palo Alto, CA, USA) and 1H nuclear mag-
netic resonance (NMR) spectrometry (400 mHz, INOVA 
400 NMR spectrometer, Varian Inc.).
synthesis of DMNcs
First, 1 mmol of iron chloride and 20 mg of as-synthesized 
pyrenyl dextran were dissolved in a solution containing 
15 mL of DEG and 5 mL of ethylene glycol.38 After complete 
solubilization, 1.50 g of sodium acetate was added and the 
mixture was continuously stirred. The resulting mixture was 
then sealed in a Teflon stainless steel autoclave at 220°C for 
6 hours. After cooling, the viscous black product was washed 
with ethanol and deionized water three times followed by 
magnetic separation.
cell culture
RAW264.7 cells from a macrophage cell line were obtained 
from the American Type Culture Collection (Manassas, VA, 
USA). The cells were maintained in Dulbecco’s Modified 
Eagle Medium supplemented with 10% fetal bovine serum 
and 1% antibiotic-antimycotic at 37°C with 5% CO
2
.
cytotoxicity test for DMNcs
The in vitro cytotoxicity of DMNCs was evaluated by 
measuring the inhibition of cell growth by a 3-[4,5-
 dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide 
(MTT) assay of RAW264.7 cells. The cells were seeded 
in a 96-well plate at a density of 2 × 104 cells per well and 
allowed to grow overnight. The cells were then treated with 
One-pot
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Dextran-encrusted
magnetic nanoclusters
(DMNCs)
Macrophage
Nucleus
Atherosclerosis detection
via
MR imaging
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Cl Cl
Cl
Fe
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Figure 1 schematic representation of the synthesis of DMNcs enabling 
atherosclerosis-targeted Mr imaging. 
Abbreviations: DMNcs, dextran-encrusted magnetic nanoclusters; Mr, magnetic 
resonance.
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DMNCs at various concentrations for a further 24 hours. The 
yellow tetrazolium salt in the MTT solution was reduced 
to purple formazan crystals in the live cells. Cell viability 
was determined by calculating the ratio of the intensity of 
purple formazan in the viable cells treated with DMNCs to 
the intensity in nontreated control cells.39
cellular uptake of DMNcs
The uptake of DMNCs was determined by Prussian blue 
staining. Two million cells per well of the RAW264.7 
 (macrophage) cell line were incubated overnight with 
 Dulbecco’s Modified Eagle Medium in six-well plates. The 
cells were further incubated with DMNCs (125 µg/mL) in 
serum-free medium for 8 hours. After washing, the cells were 
collected in phosphate-buffered saline using a cell scraper. 
The cells were then stained with Prussian blue stain and 
viewed under a light microscope. The cells were fixed in 95% 
alcohol for 5 minutes followed by immersion in iron staining 
solution (20% hydrochloric acid to potassium ferrocyanate, 
1:1) for 30 minutes at room temperature. To remove the 
residual staining solution, the samples were next rinsed with 
deionized water three times. Finally, the cells were stained 
with nuclear fast red staining solution for 15 minutes. The 
cells were then washed three times with deionized water, fol-
lowed by fixation in increasing concentrations of alcohol and 
xylene. Tissue samples were analyzed using a virtual micro-
scope (Olympus BX51, Tokyo, Japan) and Olyvia software. 
A transmission electron microscope was used to confirm 
internalization of the DMNCs by macrophage cells.
Mr imaging procedure
The MR experiments were performed using a 1.5 T clinical 
MR imaging instrument equipped with a micro-47 surface 
coil (Intera, Philips Medical Systems, Best, the  Netherlands). 
The R2 relaxivities of the DMNCs were measured using 
the Carr–Purcell–Meiboom–Gill sequence at room 
temperature: TR, 10 seconds; 32 echoes with 12 msec even 
echo space; number of acquisitions, 1; a point resolution of 
156 × 156 mm; and section thickness of 0.6 mm. For acquisi-
tion of T2-weighted MR images for the DMNC solution, the 
following parameters were used: resolution 234 × 234 mm; 
section thickness 2.0 mm; TE 60 msec; TR 4,000 msec; 
and number of acquisitions, 1. The relaxivity coefficient 
(mM−1 s−1) equals the ratio of R2 (1/T2, s−1) to DMNC 
concentration. For the in vivo MR imaging experiments, 
the following parameters were used at room temperature: 
TR 4,000 msec even echo space; number of acquisitions, 1; 
point resolution 312 × 312 mm; section thickness 0.6 mm; 
and a TE of 60 msec. The results are shown as the mean ± 
standard deviation.
animal experiments
All animal experiments were conducted using Sprague-
 Dawley rats and with approval from the International Associ-
ation for Assessment and Accreditation of Laboratory Animal 
Care. We used a rat balloon injury model for investigation of 
atherosclerosis imaging.40,41 A 3:1 blend of Zoletil–Rompun 
was first used to anesthetize the rats (300–350 g). The surgical 
area below the chin of each rat was then sterilized, and an 
incision was made using sharp serrated-edge  scissors. Next, 
using fine forceps, a blunt dissection was done to expose 
all glands. The glands were gently separated to expose the 
underlying muscular layer; this was followed by separation of 
the muscular tissue, leading to exposure of the left common 
carotid artery, the vagus nerve, and other adjacent nerves 
and vessels, which were then separated. Blunt dissection 
was further continued to expose the carotid artery bifurca-
tion into the internal and external branches. Next, while the 
left distal common carotid was tightly tied for hemostasis, 
one approximately 3-inch 4-0 silk suture was loosely tied 
around the external carotid artery branch. A Fogarty arterial 
embolectomy catheter was introduced through the external 
carotid artery and guided through the common carotid artery 
down to the aortic arch. The balloon was then slowly inflated 
with saline to generate slight resistance and the catheter was 
withdrawn along the full length of the thoracic-abdominal 
aorta; this procedure was repeated eight times. The catheter 
was removed after carotid arterial injury, and the external 
carotid was occluded by closing the skin incision with sutures. 
The surgical area was swabbed to prevent infection. After 3 
weeks, the common carotid arteries were again separated, 
as previously described, and the common carotid artery was 
exposed to a 10% FeCl
3
 solution for 5 minutes to develop 
thrombus by means of a chemical burn. The incision was then 
tightly sutured. We then performed our in vivo MR imag-
ing experiments. DMNCs (4.8 mg
Fe
/kg) were administered 
via intravenous injection into the tail vein. After 5 hours, 
the common carotid artery was excised and the rats were 
euthanized.40,41
histological analysis
A frozen section procedure was performed on the extracted 
common carotid artery, and the Masson’s trichrome 
and Prussian blue staining methods were used. Using a 
previously established protocol, we verified the inter-
nal and external common carotid artery structures by 
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Masson’s trichrome staining.42–44 In addition, the common 
carotid artery was stained with Prussian blue dye to confirm 
the presence of DMNCs at the target sites. The common 
carotid artery slides were fixed in 95% alcohol for 5  minutes 
followed by immersion in iron staining solution (20% hydro-
chloric acid to potassium ferrocyanate, 1:1) for 30 minutes 
at room temperature. To remove the residual staining solu-
tion, the samples were then rinsed three times with deion-
ized water. Finally, the tissues were stained with nuclear 
fast red staining solution for 15 minutes. The tissues were 
then washed three times with deionized water, and fixed in 
increasing concentrations of alcohol and xylene. The stained 
slides were analyzed using a virtual microscope (Olympus 
BX51) and Olyvia software.
statistical analysis
All data represent triplicate experiments, with each experi-
ment yielding comparable results. Statistical evaluation 
was performed using analysis of variance and the Student’s 
t-test. A P-value ,0.001 was considered to be statistically 
significant.
Results and discussion
synthesis and characterization  
of pyrenyl dextran
A modified “one-pot” method was developed for synthesis 
of water-soluble DMNCs for use as an atherosclerosis 
targeting MR contrast agent using pyrenyl dextran as a 
surfactant. Iron (III) chloride was used as a single iron 
precursor, sodium acetate was used as a reducing agent, 
and DEG and ethylene glycol were used as the high boiling 
point polar solvents. Pyrenyl dextran was first synthesized 
as a stabilizer by esterification of 1-pyrenebutyric acid as 
a hydrophobic moiety and dextran as a hydrophilic moiety 
using DCC and 4-dimethylaminopyridine (see Figure S1).32,33 
Synthesis of pyrenyl dextran was confirmed by Fourier-
transform infrared and 1H-NMR spectra.  Generation of 
its ester group was observed as an absorption peak at 
1,727 cm−1 in the Fourier-transform infrared spectra (see 
Figure S2). 1H-NMR peaks were observed at 7.71 ppm, 8.12 
ppm (–CH– from 1-pyrenebutyric acid), 2.03 ppm (–CH
2
– 
from 1- pyrenebutyric acid), 4.81 ppm and 4.78 ppm (–OH 
from  dextran), and 3.40 ppm and 3.71 ppm (–CH
2
– from 
dextran, see Figure S3). These results demonstrate the effec-
tive synthesis of pyrenyl dextran via the bioconjugation 
approach. Pyrenyl dextran was selected on the basis of its 
electrochemical properties, in that it can provide electrons 
for the iron  cations on the magnetic nanocluster surface and 
can serve as an electrostatic stabilizer.32,33
synthesis of DMNcs
DMNCs were then fabricated via one-pot synthesis in a solu-
tion phase at high temperature for high magnetic sensitivity. 
This method does not require any extra surface modifica-
tion steps. In this synthetic process, the above-synthesized 
pyrenyl dextran is used as a surfactant to provide a stable 
colloidal dispersion of DMNCs and to avoid aggregation. 
Ethylene glycol is introduced along with DEG as a polar 
solvent, because DEG alone leads to formation of a sheet-
like structure as compared with the monodispersed magnetic 
nanoclusters formed when ethylene glycol is used with a 
DEG to ethylene glycol ratio of 3:1.38,45,46
DMNCs were formed by a previously recommended 
two-step growth prototype, with nucleation in a supersatu-
rated solution as the first step followed by aggregation into 
larger secondary particles.47 Using this process, addition of 
sodium acetate appears to be important as it seems to be 
involved in the reduction of iron (III) chloride to iron oxide. 
Control experiments were also performed, and showed that 
Fe3+ could not be reduced in the absence of sodium acetate 
under the same reaction conditions. In particular, pyrenyl 
dextran could help in size control as well as increasing the 
colloidal stability in this synthetic method.
characterization of DMNcs
The size and surface charge of the DMNCs as measured 
by laser scattering was 65.6±4.3 nm and 2.3±0.3 mV, 
 respectively. Figure 2A and B shows the transmission elec-
tron microscopic and scanning electron microscopic images, 
respectively. Using a transmission electron microscope, the 
spherical shape of the DMNCs with a narrow size distri-
bution was observed, along with little aggregation, which 
Figure 2 (A) Transmission electron microscopic image and (B) scanning electron 
microscopic image of dextran-encrusted magnetic nanoclusters.
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may have been due to the presence of van der Waals forces 
during the DMNC drying process.48,49 To confirm colloidal 
stability, DMNCs were redispersed in various concentrations 
of fetal bovine serum (0%, 25%, 50%, and 75%) and their 
average size was then analyzed by dynamic laser scattering. 
As shown in Figure 3, the sizes were very similar, confirm-
ing that the DMNCs had high stability independent of serum 
concentration.
Thermogravimetric analysis was performed to assess the 
quantity of the pyrenyl dextran layer. The quantity of mag-
netic nanoclusters was approximately 87% and the quantity 
of the organic fraction was found to be 13% (Figure 4A). 
X-ray diffraction patterns were determined for the DMNCs, 
and their diffraction peaks closely resembled those of Fe
3
O
4
 
(JCPDS 10-319), suggesting the existence of a mixed spinel 
structure and high crystallinity in the DMNCs, irrespective 
of the presence of pyrenyl dextran (Figure 4B).
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Figure 3 average size of dextran-encrusted magnetic nanoclusters in various 
concentrations of FBs 0%, 25%, 50% and 75%. 
Abbreviation: FBs, fetal bovine serum.
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Figure 4 (A) Thermogravimetric analysis, (B) X-ray diffraction patterns of magnetic nanoclusters (black) and dextran-encrusted magnetic nanoclusters (red). (C) Magnetic 
hysteresis loops of dextran-encrusted magnetic nanoclusters at 273 K, and (D) elemental composition of the surface using X-ray photoelectron spectroscopy of 
dextran-encrusted magnetic nanoclusters.
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Abbreviation: Mr, magnetic resonance.
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Figure 6 Viability of raW264.7 cells treated with various concentrations of 
dextran-encrusted magnetic nanoclusters.
Figure 7 Prussian blue-stained microscopic images of raW264.7 cells treated 
without and with dextran-encrusted magnetic nanoclusters. 
Abbreviations: NT, nontreated; T, treated.
Figure 8 Transmission electron microscopic images of raW264.7 cells treated 
with dextran-encrusted magnetic nanoclusters.
Magnetization and T2 relaxivity  
of DMNcs
To evaluate the magnetic response of DMNCs to an external 
field, saturation of magnetization was measured at 298 K. 
The superparamagnetic behavior of DMNCs was indicated 
by the absence of a hysteresis loop; their saturation mag-
netization was measured to be 60.1 emu/g
Fe
 (Figure 4C). In 
addition, X-ray photoelectron spectroscopy demonstrated 
the presence of oxygen (O) and carbon (C) element spectra 
on the surface (Figure 4D). The element iron was barely 
detected (4.68%), indicating successful encrusting of iron 
within the pyrene dextran. The potential of the DMNCs to 
act as an MR contrast agent was estimated by evaluating 
their MR signal intensity. Figure 5A shows the T2-weighted 
MR image along with the color map displaying a decrease 
in intensity as the DMNC concentration decreased. This 
behavior demonstrates that DMNCs can be used as effective 
T2 MR contrast agents. The r2 value was calculated to be 
234.2 mM−1sec−1 (Figure 5B).
cytotoxicity assay and cellular  
uptake of DMNcs
Cytotoxicity of the DMNCs was examined by MTT assay 
using a RAW264.7 macrophage cell lines. Cell viability was 
more than 80% on exposure to DMNCs, with no disruption of 
cell proliferation, even at a high concentration (9.0 mg
Fe
/mL, 
Figure 6). Next, the macrophage cell line was treated with 
DMNCs to investigate cellular internalization. Prussian 
blue staining was used to visualize the iron content in the 
DMNC-treated cells. An acid solution of ferrocyanides in 
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Prussian blue stain combines with any ferric (III) ion present 
in the cell, leading to formation of a bright blue pigment. In 
Figure 7, prominent blue spots indicated significant binding 
of DMNCs to the cells. In comparison, blue spots were not 
observed in nontreated cells. A large number of black clusters 
were observed in the cytoplasm of the macrophage cells, 
indicating engulfment of DMNCs via a specific interaction 
which did not damage the cell nucleus (Figure 8).
In vivo Mr imaging study
We then performed in vivo MR imaging experiments to 
investigate the targeting capability of the DMNCs and their 
potential to enhance the MR image contrast. A rat balloon 
carotid injury model was used for this experiment. MR 
images were obtained before and up to 3 hours after intra-
venous injection of 4.8 mg
Fe
/kg, as shown in Figure 9A.50 As 
soon as the DMNCs were administered, the atherosclerotic 
lesion became noticeably darker, with a high MR signal, 
reaching the maximal ∆R2/R2
Pre
 (%) value of approximately 
126.5% (Figure 9A), indicating that DMNCs were delivered 
successfully and accumulated in the lesion. After the MR 
study, the common carotid arteries were excised, and the 
presence of DMNCs on the interior wall of the common 
carotid artery was confirmed by histological staining (using 
Masson’s trichrome and Prussian blue stains) to explore the 
correlation with in vivo MR images. Figure 9C(i) shows 
thrombus and its adhesion in the injured common carotid 
artery. The blue spots, which indicate the iron content in the 
DMNCs, were particularly observed in thrombus-induced 
lesions, as shown in Figure 9C(ii). These results indicate that 
DMNCs can provide MR signal enhancement in detection of 
atherosclerosis by accumulating in large quantities in mac-
rophages because of the strong interaction between dextran 
and the scavenger receptor of the macrophage.
Conclusion
We have developed a one-pot solution phase synthetic 
method for water-soluble DMNCs that can be used to detect 
atherosclerosis by targeted MR imaging. The as-synthesized 
particles showed high colloidal stability and low cytotoxicity 
as well as high saturation magnetization at room temperature. 
 Additionally, in vitro and in vivo MR studies demonstrated 
the suitability of DMNCs as effective contrast agents.  Definitive 
diagnosis of atherosclerosis may require macrophage-based 
detection, and with further optimization, the results of this 
study may potentially have clinical application.
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Figure S1 schematic illustration of synthesis of pyrenyl dextran.
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Figure S2 Fourier-transform infrared spectrum for pyrenyl dextran.
Note: *Newly formed ester bond at 1,727 cm−1.
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Figure S3 1h-nuclear magnetic resonance spectrum for pyrenyl dextran.
Abbreviation: DMsO, dimethyl sulfoxide.
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